Filing Details

Accession Number:
0001209191-20-060558
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-25 17:16:11
Reporting Period:
2020-11-25
Accepted Time:
2020-11-25 17:16:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623526 Stoke Therapeutics Inc. STOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522780 Md M. Edward Kaye C/O Stoke Therapeutics, Inc.
45 Wiggins Avenue
Bedford MA 01730
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-25 12,848 $50.00 37,152 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.